Moreover, employing the SurvExpress platform, we found evidence that colon cancer patients with higher cancer risk exhibited lower levels of SALL2 and AXIN2 compared to those with lower cancer risk (Figure 6g). This evidence concerns the gene AXIN2 and malignant colon neoplasm.